Activity of glycogen synthase kinase-3beta is down-regulated during transient differentiation of human colon cancer

Z Tuhackova1, E Sloncova, J Hlavacek

  • 1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 166 37 Praha 6, Czech Republic.

Oncology Reports
|June 22, 1999
PubMed

Insights

Sodium butyrate treatment increases protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) phosphorylation in HT-29 cells. This suggests the phosphatidylinositol-3

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Cancer research

Background:

  • Sodium butyrate is a potent differentiating agent used in cancer research.
  • HT-29 cells are a human colorectal adenocarcinoma cell line often used to study differentiation.
  • Protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) are key intracellular signaling molecules.

Purpose of the Study:

  • To investigate the early effects of sodium butyrate on intracellular signaling pathways in HT-29 cells.
  • To determine the role of the phosphatidylinositol-3' kinase (PI3'-kinase)/PKB signaling pathway in butyrate-induced differentiation.

Main Methods:

  • Treatment of HT-29 cells with sodium butyrate.
  • Assessment of protein phosphorylation and kinase activity using biochemical assays.
  • Inhibition of phosphatidylinositol-3' kinase (PI3'-kinase) with wortmannin.

Main Results:

  • Early increase in protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) phosphorylation upon butyrate treatment.
  • Inhibition of GSK-3beta activity towards its substrate, translation initiation factor eIF2B.
  • Wortmannin reduced PKB and GSK-3 phosphorylation, indicating PI3'-kinase pathway involvement.

Conclusions:

  • The PI3'-kinase/PKB-dependent signaling pathway is modulated early during transient in vitro differentiation of HT-29 cells.
  • Control of this pathway may be implicated in the early changes of the malignant phenotype of HT-29 cells.
  • These findings highlight a potential therapeutic target for colorectal cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...